-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
The net result for the period of deducting operating expenses from operating revenues.
-
Summary
-
Akoya Biosciences, Inc. quarterly/annual Operating Income (Loss) history and growth rate from Q1 2020 to Q3 2024.
- Akoya Biosciences, Inc. Operating Income (Loss) for the quarter ending September 30, 2024 was -$8.35M, a 27.7% increase year-over-year.
- Akoya Biosciences, Inc. Operating Income (Loss) for the twelve months ending September 30, 2024 was -$50.5M, a 23.3% increase year-over-year.
- Akoya Biosciences, Inc. annual Operating Income (Loss) for 2023 was -$57.7M, a 12.8% increase from 2022.
- Akoya Biosciences, Inc. annual Operating Income (Loss) for 2022 was -$66.1M, a 68.2% decline from 2021.
- Akoya Biosciences, Inc. annual Operating Income (Loss) for 2021 was -$39.3M, a 227% decline from 2020.
Operating Income (Loss), Trailing 12 Months (USD)
Operating Income (Loss), Quarterly (USD)
Operating Income (Loss), YoY Quarterly Growth (%)